SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:SPNT • BMG8192H1060

20.29 USD
+0.1 (+0.5%)
At close: Feb 4, 2026
20.29 USD
0 (0%)
After Hours: 2/4/2026, 8:04:00 PM
Fundamental Rating

4

SPNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 147 industry peers in the Insurance industry. SPNT may be in some trouble as it scores bad on both profitability and health. SPNT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • SPNT had positive earnings in the past year.
  • SPNT had a positive operating cash flow in the past year.
  • SPNT had positive earnings in 4 of the past 5 years.
  • SPNT had a positive operating cash flow in each of the past 5 years.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

  • SPNT's Return On Assets of 1.49% is in line compared to the rest of the industry. SPNT outperforms 44.22% of its industry peers.
  • SPNT has a Return On Equity of 8.39%. This is comparable to the rest of the industry: SPNT outperforms 40.82% of its industry peers.
  • With a Return On Invested Capital value of 2.65%, SPNT perfoms like the industry average, outperforming 55.10% of the companies in the same industry.
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROIC 2.65%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • SPNT's Profit Margin of 6.49% is on the low side compared to the rest of the industry. SPNT is outperformed by 60.54% of its industry peers.
  • In the last couple of years the Profit Margin of SPNT has declined.
  • Looking at the Operating Margin, with a value of 13.29%, SPNT is in line with its industry, outperforming 55.78% of the companies in the same industry.
  • SPNT's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.29%
PM (TTM) 6.49%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

3

2. Health

2.1 Basic Checks

  • SPNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, SPNT has less shares outstanding
  • SPNT has more shares outstanding than it did 5 years ago.
  • SPNT has a better debt/assets ratio than last year.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • SPNT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as SPNT would need 3.21 years to pay back of all of its debts.
  • SPNT's Debt to FCF ratio of 3.21 is in line compared to the rest of the industry. SPNT outperforms 46.26% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that SPNT is not too dependend on debt financing.
  • SPNT's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. SPNT outperforms 51.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Altman-Z N/A
ROIC/WACC0.3
WACC8.73%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

  • The earnings per share for SPNT have decreased by 0.00% in the last year.
  • Measured over the past years, SPNT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.97% on average per year.
  • Looking at the last year, SPNT shows a small growth in Revenue. The Revenue has grown by 2.43% in the last year.
  • SPNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.87% yearly.
EPS 1Y (TTM)0%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%2333.33%
Revenue 1Y (TTM)2.43%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%15.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 43.31% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, SPNT will show a small growth in Revenue. The Revenue will grow by 3.67% on average per year.
EPS Next Y155%
EPS Next 2Y61.01%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue Next Year-2.66%
Revenue Next 2Y2.38%
Revenue Next 3Y3.67%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.76, the valuation of SPNT can be described as correct.
  • SPNT's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of SPNT to the average of the S&P500 Index (28.25), we can say SPNT is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 8.15, the valuation of SPNT can be described as very reasonable.
  • 68.71% of the companies in the same industry are more expensive than SPNT, based on the Price/Forward Earnings ratio.
  • SPNT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 12.76
Fwd PE 8.15
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SPNT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SPNT is cheaper than 68.03% of the companies in the same industry.
  • SPNT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.13
EV/EBITDA 6.28
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SPNT's earnings are expected to grow with 43.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y61.01%
EPS Next 3Y43.31%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for SPNT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SIRIUSPOINT LTD

NYSE:SPNT (2/4/2026, 8:04:00 PM)

After market: 20.29 0 (0%)

20.29

+0.1 (+0.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners87.28%
Inst Owner Change-0.09%
Ins Owners1.59%
Ins Owner Change-6.84%
Market Cap2.37B
Revenue(TTM)2.86B
Net Income(TTM)185.50M
Analysts82.5
Price Target22.95 (13.11%)
Short Float %1.68%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP8.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.28%
Min EPS beat(2)-13.77%
Max EPS beat(2)40.33%
EPS beat(4)2
Avg EPS beat(4)0.89%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)5
Avg EPS beat(8)14.3%
EPS beat(12)8
Avg EPS beat(12)37.79%
EPS beat(16)9
Avg EPS beat(16)12%
Revenue beat(2)1
Avg Revenue beat(2)1.95%
Min Revenue beat(2)-9.34%
Max Revenue beat(2)13.24%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-8.18%
EPS NY rev (1m)0%
EPS NY rev (3m)32.6%
Revenue NQ rev (1m)4.21%
Revenue NQ rev (3m)4.21%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE 12.76
Fwd PE 8.15
P/S 0.83
P/FCF 11.13
P/OCF 11.13
P/B 1.07
P/tB 1.14
EV/EBITDA 6.28
EPS(TTM)1.59
EY7.84%
EPS(NY)2.49
Fwd EY12.27%
FCF(TTM)1.82
FCFY8.98%
OCF(TTM)1.82
OCFY8.98%
SpS24.47
BVpS18.92
TBVpS17.86
PEG (NY)0.08
PEG (5Y)N/A
Graham Number26.02
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROCE 3.06%
ROIC 2.65%
ROICexc 2.78%
ROICexgc 3.78%
OM 13.29%
PM (TTM) 6.49%
GM N/A
FCFM 7.45%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Debt/EBITDA 1.74
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 54.38%
Profit Quality 114.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.73%
ROIC/WACC0.3
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%2333.33%
EPS Next Y155%
EPS Next 2Y61.01%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue 1Y (TTM)2.43%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%15.21%
Revenue Next Year-2.66%
Revenue Next 2Y2.38%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
EBIT growth 1Y-22.34%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.16%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-51.16%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%

SIRIUSPOINT LTD / SPNT FAQ

What is the fundamental rating for SPNT stock?

ChartMill assigns a fundamental rating of 4 / 10 to SPNT.


What is the valuation status for SPNT stock?

ChartMill assigns a valuation rating of 6 / 10 to SIRIUSPOINT LTD (SPNT). This can be considered as Fairly Valued.


Can you provide the profitability details for SIRIUSPOINT LTD?

SIRIUSPOINT LTD (SPNT) has a profitability rating of 3 / 10.


How financially healthy is SIRIUSPOINT LTD?

The financial health rating of SIRIUSPOINT LTD (SPNT) is 3 / 10.


What is the earnings growth outlook for SIRIUSPOINT LTD?

The Earnings per Share (EPS) of SIRIUSPOINT LTD (SPNT) is expected to grow by 155% in the next year.